The BCW Index climbed 1.59 percent for the trading week ended Tuesday. Only five of the components of the Index declined for the week, and none of them dropped more than 1.6 percent. Stratagene led gainers for the tracking period, closing up 6.7 percent.

In comparison, the Dow Jones Industrial Average gained .9 percent, while both the Nasdaq and Nasdaq Biotech Index rose 2.6 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.